Authors:
DEPRAETERE H
AJZENBERG N
GIRMA JP
LACOMBE C
MEYER D
DECKMYN H
BARUCH D
Citation: H. Depraetere et al., PLATELET-AGGREGATION INDUCED BY A MONOCLONAL-ANTIBODY TO THE A1 DOMAIN OF VON-WILLEBRAND-FACTOR, Blood, 91(10), 1998, pp. 3792-3799
Authors:
GIRMA JP
FRESSINAUD E
HOULLIER A
LAURIAN Y
AMIRAL J
MEYER D
Citation: Jp. Girma et al., ASSAY OF FACTOR-VIII ANTIGEN (VIII-CAG) IN 294 HEMOPHILIA-A PATIENTS BY A NEW COMMERCIAL ELISA USING MONOCLONAL-ANTIBODIES, Haemophilia, 4(2), 1998, pp. 98-103
Authors:
GIRMA JP
FRESSINAUD E
HOULLIER A
LAURIAN Y
AMIRAL J
MEYER D
Citation: Jp. Girma et al., NEW ELISA FOR THE MEASUREMENT OF FACTOR-VIII (VIII-CAG) USING MONOCLONAL-ANTIBODIES, Thrombosis and haemostasis, 1997, pp. 119-119
Authors:
BELLUCCI S
GIRMA JP
LOZANO M
MEYER D
CAEN JP
Citation: S. Bellucci et al., IMPAIRED PROTHROMBIN CONSUMPTION IN BERNARD-SOULIER-SYNDROME IS CORRECTED IN-VITRO BY HUMAN FACTOR-VIII, Thrombosis and haemostasis, 1997, pp. 278-278
Authors:
RIBBA AS
CHEREL G
OBERT B
GIRMA JP
MEYER D
Citation: As. Ribba et al., BOTH LYSINE-643 AND LYSINE-644 IN THE A1 LOOP OF VON-WILLEBRAND-FACTOR ARE NECESSARY FOR THE INTERACTION WITH GLYCOPROTEIN IB, Thrombosis and haemostasis, 1997, pp. 1494-1494
Authors:
NISHIKUBO T
CHRISTOPHE O
LAVERGNE JM
OBERT B
NONAMI K
TAKAHASHI Y
YOSHIOKA A
MEYER D
GIRMA JP
Citation: T. Nishikubo et al., ABNORMAL PROTEOLYTIC PROCESSING OF VON-WILLEBRAND-FACTOR ARG611CYS AND ARG611HIS, Thrombosis and haemostasis, 1997, pp. 1589-1589
Authors:
BELLUCCI S
GIRMA JP
LOZANO M
MEYER D
CAEN JP
Citation: S. Bellucci et al., IMPAIRED PROTHROMBIN CONSUMPTION IN BERNARD-SOULIER SYNDROME IS CORRECTED IN-VITRO BY HUMAN FACTOR-VIII, Thrombosis and haemostasis, 77(2), 1997, pp. 383-386
Authors:
NISHIKUBO T
CHRISTOPHE O
LAVERGNE JM
OBERT B
NONAMI K
TAKAHASHI Y
YOSHIOKA A
MEYER D
GIRMA JP
Citation: T. Nishikubo et al., ABNORMAL PROTEOLYTIC PROCESSING OF VON-WILLEBRAND-FACTOR ARG611CYS AND ARG611HIS, Thrombosis and haemostasis, 77(1), 1997, pp. 174-182
Authors:
AJZENBERG N
DEPRAETERE H
GIRMA JP
MEYER D
BARUCH D
Citation: N. Ajzenberg et al., PLATELET-AGGREGATION INDUCED BY A MONOCLONAL-ANTIBODY TO VON-WILLEBRAND-FACTOR, Atherosclerosis, 134(1-2), 1997, pp. 182-182
Authors:
SIGURET V
RIBBA AS
CHRISTOPHE O
CHERET G
OBERT B
ROUAULT C
NISHIKUBO T
MEYER D
GIRMA JP
PIETU G
Citation: V. Siguret et al., CHARACTERIZATION OF RECOMBINANT VON-WILLEBRAND-FACTORS MUTATED ON CYSTEINE-509 OR CYSTEINE-509695, Thrombosis and haemostasis, 76(3), 1996, pp. 453-459
Citation: Jp. Girma et al., STRUCTURE-FUNCTION RELATIONSHIP OF THE A1 DOMAIN OF VON-WILLEBRAND-FACTOR, Thrombosis and haemostasis, 74(1), 1995, pp. 156-160
Authors:
RIBBA AS
SIGURET V
CHEREL G
CHRISTOPHE O
OBERT B
NISHIKUBO T
GIRMA JP
PIETU G
MEYER D
Citation: As. Ribba et al., CYSTEINE-509 AND CYSTEINE-695 OF VON-WILLEBRAND-FACTOR PLAY A DISTINCT ROLE IN THE BINDING TO PLATELET GLYCOPROTEIN-IB, Thrombosis and haemostasis, 73(6), 1995, pp. 1159-1159
Authors:
CHRISTOPHE O
ROUAULT C
OBERT B
PIETU G
MEYER D
GIRMA JP
Citation: O. Christophe et al., A MONOCLONAL-ANTIBODY (B724) TO VON-WILLEBRAND-FACTOR RECOGNIZING AN EPITOPE WITHIN THE A1 DISULFIDE LOOP (CYS509-CYS695) DISCRIMINATES BETWEEN TYPE 2A AND TYPE 2B VON-WILLEBRAND DISEASE, British Journal of Haematology, 90(1), 1995, pp. 195-203
Authors:
MINCKES O
FREYSSINET JM
ROUAULT C
PAVIRANI A
RASMUSSEN U
BOYERNEUMANN C
MEYER D
GIRMA JP
Citation: O. Minckes et al., INTERACTION OF VON-WILLEBRAND-FACTOR WITH PLATELETS ACTIVATED BY THROMBIN OR A SYNTHETIC 7-AMINO ACID PEPTIDE DERIVED FROM THE CLEAVED THROMBIN RECEPTOR, Comptes rendus de l'Academie des sciences. Serie 3, Sciences de la vie, 317(4), 1994, pp. 363-370
Authors:
RIBBA AS
CHRISTOPHE O
DERLON A
CHEREL G
SIGURET V
LAVERGNE JM
GIRMA JP
MEYER D
PIETU G
Citation: As. Ribba et al., DISCREPANCY BETWEEN IIA-PHENOTYPE AND IIB-GENOTYPE IN A PATIENT WITH A VARIANT OF VON-WILLEBRAND DISEASE, Blood, 83(3), 1994, pp. 833-841
Authors:
CHRISTOPHE O
RIBBA AS
BARUCH D
OBERT B
ROUAULT C
NIINOMI K
PIETU G
MEYER D
GIRMA JP
Citation: O. Christophe et al., INFLUENCE OF MUTATIONS AND SIZE OF MULTIMERS IN TYPE-II VON-WILLEBRAND DISEASE UPON THE FUNCTION OF VON-WILLEBRAND-FACTOR, Blood, 83(12), 1994, pp. 3553-3561
Authors:
LAVERGNE JM
PIAO Y
RIBBA AS
GIRMA JP
SIGURET V
PIETU G
BOYERNEUMANN C
SCHANDELONG A
BAHNAK BR
MEYER D
Citation: Jm. Lavergne et al., FUNCTIONAL-ANALYSIS OF THE ARG91GLN SUBSTITUTION IN THE FACTOR-VIII BINDING DOMAIN OF VON-WILLEBRAND-FACTOR DEMONSTRATES VARIABLE PHENOTYPIC-EXPRESSION, Thrombosis and haemostasis, 70(4), 1993, pp. 691-696
Authors:
PIAO YC
LAVERGNE JM
GIRMA JP
ROTHSCHILD C
SIE P
BAHNAK BR
MEYER D
Citation: Yc. Piao et al., STUDY OF THE FACTOR-VIII-BINDING DOMAIN OF VON-WILLEBRAND-FACTOR IN 55 PATIENTS WITH VARIOUS TYPES OF VON-WILLEBRAND DISEASE, Thrombosis and haemostasis, 69(6), 1993, pp. 559-559
Authors:
BIHOREAU N
LAYET S
GIRMA JP
PAOLANTONACCI P
DHAINAUT F
AUPART MPF
Citation: N. Bihoreau et al., PRECLINICAL STUDIES OF A DELETED RECOMBINANT FACTOR-VIII III FUNCTIONAL AND STRUCTURAL CHARACTERIZATION/, Thrombosis and haemostasis, 69(6), 1993, pp. 852-852
Authors:
GIRMA JP
CHRISTOPHE O
ROUAULT C
OBERT B
PIETU G
MEYER D
Citation: Jp. Girma et al., MONOCLONAL ANTIBODY-B-724 AGAINST AN EPITOPE LOCATED WITHIN THE A1-CYS 509-695 DISULFIDE LOOP OF VON-WILLEBRAND-FACTOR IS A USEFUL TOOL TO DISCRIMINATE VARIANTS OF VON-WILLEBRAND DISEASE, Thrombosis and haemostasis, 69(6), 1993, pp. 948-948
Authors:
SIGURET V
RIBBA AS
CHRISTOPHE O
GIRMA JP
CHEREL G
MEYER D
PIETU G
Citation: V. Siguret et al., RECOMBINANT VON-WILLEBRAND-FACTOR MUTATED ON CYS-695 DEMONSTRATES THECRUCIAL ROLE OF THE AMINO-ACID IN BINDING TO PLATELET GLYCOPROTEIN-IB, Thrombosis and haemostasis, 69(6), 1993, pp. 980-980
Authors:
MINCKES O
FREYSSINET JM
PAVIRANI A
RASMUSSEN UB
MEYER D
GIRMA JP
Citation: O. Minckes et al., INTERACTION OF VON-WILLEBRAND-FACTOR WITH PLATELETS ACTIVATED BY THROMBIN OR A SYNTHETIC 7-AMINO ACID PEPTIDE DERIVED FROM THE CLEAVED THROMBIN RECEPTOR, Thrombosis and haemostasis, 69(6), 1993, pp. 1150-1150
Authors:
CHRISTOPHE O
RIBBA AS
PIETU G
BARUCH D
MEYER D
GIRMA JP
Citation: O. Christophe et al., INFLUENCE OF MUTATIONS AND SIZE OF MULTIMERS IN TYPE-II VON-WILLEBRAND DISEASE UPON THE FUNCTION OF VON-WILLEBRAND-FACTOR, Thrombosis and haemostasis, 69(6), 1993, pp. 1200-1200